April is not yet complete, but two items of interest already bear noting. One of these is perhaps the most important patent case to be heard by the Supreme Court in a long time, at least where life sciences are…
Tag Archives: Supreme Court
Election 2012: What it means for device makers
November 9, 2012 – 9:48 AM
There’s a saying that elections have consequences, an observation that has special meaning for the highly regulated medical device industry. Here are a few things for device makers to bear in mind as 2012 gives way to 2013.
The last days of 2012: Patent cases and empty seats
October 22, 2012 – 5:33 AM
There are only 70 or so days left in 2012, but that doesn’t mean there isn’t a lot of critical activity still in play. Here are a couple of things to keep track of.
Myriad at CAFC: Three points to remember
July 23, 2012 – 10:03 PM
The July 20 hearing at the Court of Appeals for the Federal Circuit addressing the Myriad case did not last a terribly long time, but there were a few object lessons to take away. We last visited this situation shortly…
Supreme Court ruling could lead to more questions than answers
June 28, 2012 – 8:36 AM
The highest court in the land is poised to make a ruling that will undoubtedly change the face of healthcare forever. As the Supreme Court is set to bury or uphold President Obama’s presidential campaign healthcare plan, there should be…
Myriad, Prometheus and life science patents: The End of Days?
April 9, 2012 – 7:53 AM
The Supreme Court decision in Mayo v. Prometheus and the Court’s remand of Myriad have provoked a lot of angst on the part of those in the life sciences. Still, the degree to which these cases might prove cataclysmic is…
Patent reform: All aboard, the train has left the station
June 21, 2011 – 8:53 AM
The U.S. House of Representatives is expecting a vote this week on its patent reform bill, but unlike passage of the Senate bill, the House bill has to deal with a potentially crippling conflict. This conflict was set up by…
